From: Role of MRI in diagnosis of prostate cancer and correlation of results with transrectal ultrasound guided biopsy “TRUS”
MRI
Biopsy
Total
Malignant
Benign
Positive
13 (43.4%) TP
4 (13.3%) FP
17 (56.7%)
Negative/ non-specific
9 (30.0%) FN
4 (13.3%) TN
13 (43.3%)
22 (73.3%)
8 (26.7%)
30 (100.0%)
Kappa (95% CI)
0.076 (0.000–0.413)
P
0.657